In This Section

12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research— Translating Knowledge into Practice

December 10-14, 2022
Hyatt Regency Maui
Maui, Hawaii

AACR Organizing Committee

Antoni Ribas, Cochair, University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, California
Alexander Marson, University of California San Francisco, San Francisco, California
Olufunmilayo I. Olopade, UChicago Medicine Comprehensive Cancer Center, Chicago, Illinois
David A. Tuveson, Cold Spring Harbor Laboratory Cancer Center; Lustgarten Foundation, Cold Spring Harbor, New York
Karen H. Vousden, The Francis Crick Institute, London, United Kingdom
Ashani T. Weeraratna, Johns Hopkins University, Baltimore, Maryland
Anna M. Wu, City of Hope, Duarte, California

JCA Organizing Committee

Masanori Hatakeyama, Cochair, Institute of Microbial Chemistry, Tokyo, Japan
Masanobu Oshima, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
Issay Kitabayashi, National Cancer Center Research Institute, Tokyo, Japan
Toru Hirota, The Cancer Institute Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
Patrick Tan, Duke-NUS Medical School, Singapore, Singapore
Naoko Ohtani, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
Junko Takita, Kyoto University, Graduate School of Medicine, Kyoto, Japan

The American Association for Cancer Research (AACR) and Japanese Cancer Association (JCA) are proud to offer this 12th AACR-JCA Joint Conference. This meeting series has a long tradition of bringing together outstanding researchers from the United States, Japan, and around the world to share their findings and present the latest advances in basic, translational, and clinical cancer research. Formal and informal interactions as well as international collaborations are fostered through this unique forum. Just as its predecessors have done, this AACR-JCA Joint Conference will take a broad view of contemporary cancer research and will be of interest to basic, translational, and clinical investigators at all career levels.




Chugai Foundation for Innovative Drug Discovery Science
Chugai Pharmaceutical Co., Ltd.
EbisuScience Corporation
Eli Lilly Japan
Guardant Health AMEA
Merck Biopharma Co., Ltd.
The Uehara Memorial Foundation

Professional Education Grant



Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available